Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Jorge Saucedo

Concepts (377)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Angioplasty, Balloon, Coronary
40
2020
176
4.410
 Why?
Acute Coronary Syndrome
25
2020
106
4.220
 Why?
Myocardial Infarction
30
2017
448
3.800
 Why?
Platelet Aggregation Inhibitors
31
2020
213
3.680
 Why?
Registries
42
2020
629
2.640
 Why?
Percutaneous Coronary Intervention
20
2020
328
2.520
 Why?
Coronary Artery Disease
16
2020
320
2.040
 Why?
Stents
21
2020
372
1.990
 Why?
Ticlopidine
16
2016
72
1.660
 Why?
Risk Assessment
20
2019
1350
1.340
 Why?
Electrocardiography
11
2016
281
1.330
 Why?
Hospital Mortality
17
2020
459
1.250
 Why?
Hemorrhage
14
2018
224
1.220
 Why?
Coronary Angiography
19
2020
388
1.190
 Why?
Myocardial Revascularization
9
2017
30
1.100
 Why?
Platelet Glycoprotein GPIIb-IIIa Complex
12
2012
46
1.100
 Why?
Drug-Eluting Stents
7
2020
102
1.090
 Why?
Coronary Disease
13
2007
165
1.070
 Why?
Hirudins
7
2016
24
1.070
 Why?
Coronary Restenosis
7
2020
39
1.050
 Why?
Aged
74
2021
10191
1.000
 Why?
Anticoagulants
12
2015
279
0.990
 Why?
Peptide Fragments
7
2016
210
0.990
 Why?
Thiophenes
8
2014
46
0.970
 Why?
Time Factors
29
2020
3000
0.920
 Why?
Piperazines
8
2014
125
0.920
 Why?
Middle Aged
74
2020
13096
0.910
 Why?
Peptides
8
2010
236
0.880
 Why?
Treatment Outcome
50
2021
5486
0.880
 Why?
Purinergic P2Y Receptor Antagonists
6
2016
35
0.840
 Why?
Cardiac Catheterization
12
2021
244
0.820
 Why?
Male
85
2021
26863
0.820
 Why?
Platelet Aggregation
9
2014
78
0.810
 Why?
Sirolimus
5
2013
72
0.810
 Why?
Postoperative Complications
8
2020
1081
0.800
 Why?
Coronary Vessels
6
2017
173
0.790
 Why?
Myocardial Ischemia
7
2010
132
0.790
 Why?
Coronary Artery Bypass
10
2015
136
0.760
 Why?
Humans
112
2021
52593
0.760
 Why?
Female
82
2021
28262
0.760
 Why?
Guideline Adherence
6
2015
143
0.750
 Why?
Risk Factors
29
2020
3952
0.730
 Why?
Practice Guidelines as Topic
10
2015
496
0.670
 Why?
Fibrinolytic Agents
5
2020
131
0.660
 Why?
Heart Transplantation
4
2015
370
0.660
 Why?
Thrombosis
6
2014
262
0.630
 Why?
United States
27
2021
5227
0.620
 Why?
Drug Substitution
3
2014
13
0.620
 Why?
Retrospective Studies
27
2020
6671
0.600
 Why?
Follow-Up Studies
17
2019
2291
0.570
 Why?
Aged, 80 and over
24
2021
3420
0.560
 Why?
Myocardial Reperfusion
3
2015
13
0.560
 Why?
Saphenous Vein
2
2015
65
0.530
 Why?
Angina, Unstable
7
2006
31
0.520
 Why?
Cardiovascular Agents
3
2020
65
0.510
 Why?
Heparin, Low-Molecular-Weight
2
2016
23
0.510
 Why?
Tyrosine
3
2004
91
0.480
 Why?
Renal Insufficiency, Chronic
3
2013
203
0.480
 Why?
Immunosuppressive Agents
5
2013
250
0.470
 Why?
Coronary Sinus
1
2015
5
0.460
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
4
2017
149
0.460
 Why?
Anastomosis, Surgical
1
2015
70
0.460
 Why?
Metals
2
2012
37
0.450
 Why?
Inpatients
3
2019
209
0.450
 Why?
Heart Valve Prosthesis
3
2021
89
0.440
 Why?
Patient Admission
1
2014
80
0.430
 Why?
Heart Valve Prosthesis Implantation
3
2021
102
0.430
 Why?
Prospective Studies
16
2021
2457
0.430
 Why?
Evidence-Based Medicine
7
2012
269
0.420
 Why?
Recombinant Proteins
8
2016
496
0.420
 Why?
Blood Platelets
6
2014
263
0.410
 Why?
Aspirin
7
2015
123
0.400
 Why?
Hemoglobins
1
2013
111
0.380
 Why?
Cardiology
3
2021
101
0.380
 Why?
Survival Rate
9
2017
952
0.370
 Why?
Severity of Illness Index
7
2018
1037
0.370
 Why?
Diabetes Mellitus, Type 1
1
2014
221
0.370
 Why?
Aorta
1
2012
170
0.360
 Why?
Blood Vessel Prosthesis Implantation
2
2012
123
0.360
 Why?
Mitral Valve
3
2020
57
0.360
 Why?
Aortic Aneurysm, Abdominal
1
2011
52
0.350
 Why?
Mitral Valve Annuloplasty
2
2021
6
0.340
 Why?
Diabetes Mellitus, Type 2
2
2014
567
0.340
 Why?
Mesenteric Artery, Superior
1
2010
10
0.330
 Why?
Ischemic Attack, Transient
2
2020
59
0.320
 Why?
Bioprosthesis
2
2021
42
0.310
 Why?
Angioplasty, Balloon
1
2010
70
0.310
 Why?
Thrombectomy
1
2010
73
0.310
 Why?
Prosthesis Design
6
2021
261
0.310
 Why?
Stroke
4
2020
515
0.310
 Why?
Kidney Diseases
1
2011
231
0.300
 Why?
Patient Discharge
5
2018
326
0.300
 Why?
Immunoglobulin Fab Fragments
3
2004
19
0.290
 Why?
Prosthesis Failure
2
2020
113
0.290
 Why?
Intracranial Hemorrhages
2
2019
41
0.290
 Why?
American Heart Association
2
2021
33
0.290
 Why?
Postoperative Hemorrhage
1
2008
55
0.290
 Why?
Chi-Square Distribution
6
2014
295
0.270
 Why?
Odds Ratio
6
2014
568
0.260
 Why?
Prognosis
9
2019
2118
0.260
 Why?
Stroke Volume
3
2019
160
0.260
 Why?
Antibodies, Monoclonal
4
2004
478
0.250
 Why?
Peripheral Arterial Disease
2
2019
77
0.240
 Why?
Cardiovascular Diseases
2
2021
495
0.240
 Why?
Internal Mammary-Coronary Artery Anastomosis
1
2005
6
0.240
 Why?
Mammary Arteries
1
2005
10
0.240
 Why?
Incidence
7
2019
1077
0.230
 Why?
Comorbidity
5
2015
631
0.230
 Why?
Ventricular Function, Left
2
2019
177
0.230
 Why?
Intermittent Claudication
3
2014
16
0.230
 Why?
Antithrombins
3
2016
22
0.230
 Why?
Heparin
1
2005
89
0.230
 Why?
Heart Valve Diseases
2
2020
55
0.220
 Why?
Coronary Stenosis
1
2005
99
0.220
 Why?
Platelet Function Tests
5
2014
22
0.200
 Why?
Vascular Diseases
2
2015
74
0.200
 Why?
Shock, Cardiogenic
2
2018
34
0.200
 Why?
Logistic Models
7
2014
934
0.200
 Why?
Administration, Oral
4
2013
455
0.200
 Why?
Aryl Hydrocarbon Hydroxylases
2
2013
76
0.200
 Why?
Double-Blind Method
7
2014
718
0.200
 Why?
Aortic Valve
2
2019
126
0.190
 Why?
Angiotensin Receptor Antagonists
2
2019
22
0.190
 Why?
Angiotensin-Converting Enzyme Inhibitors
2
2019
82
0.180
 Why?
Drug Therapy, Combination
5
2015
400
0.180
 Why?
Research Report
1
2021
18
0.180
 Why?
Receptors, Purinergic P2Y12
4
2013
17
0.180
 Why?
Recurrence
8
2018
683
0.180
 Why?
Ethics, Medical
1
2021
44
0.170
 Why?
Adrenergic beta-Antagonists
2
2018
112
0.170
 Why?
Patient Selection
7
2016
266
0.170
 Why?
Influenza, Human
1
2021
85
0.170
 Why?
Cardiac Catheters
1
2020
12
0.170
 Why?
Syndrome
6
2007
253
0.170
 Why?
Creatine Kinase
1
2000
32
0.170
 Why?
Hemostatic Techniques
3
2009
31
0.170
 Why?
Angioplasty
1
2000
21
0.160
 Why?
Hospitalization
7
2016
749
0.160
 Why?
Multivariate Analysis
7
2016
602
0.160
 Why?
Calcinosis
1
2020
52
0.160
 Why?
Renin-Angiotensin System
1
2019
58
0.150
 Why?
Cohort Studies
6
2018
1553
0.150
 Why?
Databases, Factual
4
2019
715
0.140
 Why?
Aortic Valve Stenosis
1
2019
78
0.140
 Why?
Cell Adhesion Molecules
3
2013
88
0.140
 Why?
Decision Support Techniques
1
2018
71
0.140
 Why?
Mitral Valve Insufficiency
1
2018
56
0.140
 Why?
Blood Coagulation
3
2014
62
0.140
 Why?
Graft Occlusion, Vascular
2
2012
78
0.130
 Why?
Adult
11
2015
14170
0.130
 Why?
Neoplasms
2
2017
1308
0.130
 Why?
Exercise Tolerance
2
2014
48
0.130
 Why?
Microfilament Proteins
2
2013
44
0.130
 Why?
Brachytherapy
3
2002
51
0.130
 Why?
Europe
4
2018
91
0.130
 Why?
Glomerular Filtration Rate
2
2013
130
0.120
 Why?
Radiography
4
2011
474
0.120
 Why?
Consensus
3
2021
190
0.120
 Why?
Research Design
2
2016
358
0.120
 Why?
Creatine Kinase, MB Form
2
2012
10
0.120
 Why?
Phosphoproteins
2
2013
122
0.120
 Why?
Troponin
2
2012
17
0.120
 Why?
Predictive Value of Tests
5
2018
952
0.120
 Why?
Heart Diseases
2
2012
226
0.120
 Why?
Vitamin K
1
2014
17
0.110
 Why?
Genotype
2
2014
571
0.110
 Why?
Holidays
1
2014
4
0.110
 Why?
Warfarin
1
2015
84
0.110
 Why?
Morbidity
1
2014
143
0.110
 Why?
Phenotype
2
2014
800
0.100
 Why?
Drug Prescriptions
1
2013
103
0.100
 Why?
Gene Transfer Techniques
2
2003
42
0.100
 Why?
Atrial Fibrillation
1
2015
201
0.100
 Why?
Statistics, Nonparametric
1
2013
196
0.100
 Why?
Aortography
1
2012
33
0.100
 Why?
Pharmacogenetics
1
2012
51
0.100
 Why?
Adenosine Monophosphate
1
2012
14
0.100
 Why?
Quinazolinones
1
2012
7
0.100
 Why?
Kidney Function Tests
1
2012
55
0.100
 Why?
Dose-Response Relationship, Drug
1
2016
1378
0.100
 Why?
Pyridines
1
2013
134
0.100
 Why?
Femoral Artery
3
2009
107
0.100
 Why?
Chronic Disease
2
2011
588
0.100
 Why?
Drug Delivery Systems
2
2005
148
0.100
 Why?
Propensity Score
3
2019
158
0.090
 Why?
Quality Indicators, Health Care
1
2012
91
0.090
 Why?
Bundle-Branch Block
1
2011
19
0.090
 Why?
Diabetes Complications
2
2002
125
0.090
 Why?
Aortic Rupture
1
2011
18
0.090
 Why?
Emergency Service, Hospital
2
2013
524
0.090
 Why?
Randomized Controlled Trials as Topic
5
2009
600
0.090
 Why?
Disease-Free Survival
5
2011
464
0.090
 Why?
Transportation of Patients
1
2011
39
0.090
 Why?
Sulfonamides
1
2012
134
0.090
 Why?
Hospitals
1
2012
184
0.090
 Why?
Diabetic Angiopathies
1
2011
24
0.090
 Why?
Diagnostic Imaging
1
2012
173
0.090
 Why?
Ischemia
1
2011
154
0.090
 Why?
Transplantation, Homologous
1
2011
151
0.090
 Why?
Prevalence
4
2019
1017
0.090
 Why?
Feasibility Studies
1
2012
403
0.090
 Why?
Algorithms
2
2008
668
0.090
 Why?
Patient Care Team
1
2012
273
0.080
 Why?
Graft Survival
1
2011
161
0.080
 Why?
Drug Administration Schedule
4
2014
376
0.080
 Why?
Health Services Accessibility
1
2014
438
0.080
 Why?
Fluoroscopy
1
2009
51
0.080
 Why?
Adolescent
3
2012
6737
0.080
 Why?
Genetic Vectors
2
2007
130
0.080
 Why?
Clinical Trials as Topic
3
2008
472
0.080
 Why?
Radiography, Interventional
1
2009
58
0.080
 Why?
Acute Disease
4
2014
387
0.080
 Why?
Endovascular Procedures
1
2011
179
0.080
 Why?
Thrombelastography
1
2009
27
0.080
 Why?
Preoperative Care
2
2012
174
0.080
 Why?
Multicenter Studies as Topic
4
2017
112
0.080
 Why?
Palliative Care
1
2011
216
0.070
 Why?
Emergency Treatment
1
2008
29
0.070
 Why?
Asia
2
2018
22
0.070
 Why?
Analysis of Variance
3
2009
558
0.070
 Why?
Age Factors
4
2018
1132
0.070
 Why?
Peripheral Vascular Diseases
1
2007
23
0.070
 Why?
Equipment Design
3
2020
288
0.070
 Why?
Plasmids
1
2007
167
0.070
 Why?
Kidney Failure, Chronic
1
2009
216
0.060
 Why?
International Cooperation
2
2016
52
0.060
 Why?
Thrombolytic Therapy
2
2004
112
0.060
 Why?
Young Adult
2
2012
4337
0.060
 Why?
Canada
2
2018
107
0.060
 Why?
Carrier Proteins
1
2007
320
0.060
 Why?
Coronary Vessel Anomalies
1
2005
37
0.060
 Why?
Iridium Radioisotopes
2
2002
5
0.060
 Why?
Quality of Health Care
1
2006
188
0.060
 Why?
Tennessee
1
2004
38
0.060
 Why?
Mississippi
1
2004
91
0.060
 Why?
Bradycardia
1
2004
38
0.050
 Why?
Infusions, Intravenous
1
2004
222
0.050
 Why?
Endothelial Growth Factors
1
2003
11
0.050
 Why?
Lymphokines
1
2003
20
0.050
 Why?
Oklahoma
2
2014
24
0.050
 Why?
Enoxaparin
1
2003
31
0.050
 Why?
Thrombocytopenia
1
2004
92
0.050
 Why?
Intercellular Signaling Peptides and Proteins
1
2003
107
0.050
 Why?
Neovascularization, Physiologic
1
2003
87
0.050
 Why?
Coated Materials, Biocompatible
1
2002
34
0.050
 Why?
Point-of-Care Systems
1
2003
66
0.050
 Why?
Paclitaxel
1
2002
91
0.050
 Why?
Platelet Activation
2
2013
49
0.050
 Why?
Thalidomide
1
2004
378
0.050
 Why?
Diabetes Mellitus
2
2002
318
0.050
 Why?
Tissue Adhesives
1
2001
14
0.050
 Why?
Latin America
1
2021
10
0.050
 Why?
Cell Cycle
1
2002
240
0.040
 Why?
Angioplasty, Laser
1
2001
1
0.040
 Why?
Heptanoic Acids
1
2000
35
0.040
 Why?
Anticholesteremic Agents
1
2000
32
0.040
 Why?
Pulmonary Edema
1
2000
15
0.040
 Why?
Punctures
3
2009
55
0.040
 Why?
Walking
2
2014
106
0.040
 Why?
Quality of Life
2
2007
882
0.040
 Why?
Pyrroles
1
2000
72
0.040
 Why?
Yttrium Radioisotopes
1
2000
9
0.040
 Why?
Regression Analysis
2
2016
403
0.040
 Why?
Atherectomy, Coronary
1
1999
6
0.040
 Why?
Arterial Occlusive Diseases
1
1999
81
0.040
 Why?
Vaccination
1
2021
299
0.040
 Why?
Cause of Death
1
2019
161
0.040
 Why?
Tissue Plasminogen Activator
1
1999
109
0.040
 Why?
Gender Identity
1
2018
27
0.040
 Why?
Brazil
1
2018
39
0.040
 Why?
Intra-Aortic Balloon Pumping
1
2018
7
0.040
 Why?
Length of Stay
1
2001
674
0.040
 Why?
Echocardiography, Doppler, Color
1
2018
22
0.040
 Why?
Sweden
1
2018
11
0.040
 Why?
Arkansas
1
2004
2029
0.040
 Why?
Hypolipidemic Agents
1
1998
30
0.040
 Why?
Erythrocyte Transfusion
1
2018
53
0.040
 Why?
Administration, Intravenous
1
2018
74
0.040
 Why?
Echocardiography, Transesophageal
1
2018
61
0.030
 Why?
South America
1
2017
4
0.030
 Why?
Cardiotonic Agents
1
2018
85
0.030
 Why?
North America
1
2017
77
0.030
 Why?
Recovery of Function
1
2018
202
0.030
 Why?
Methods
1
1996
53
0.030
 Why?
Equipment and Supplies
1
1996
17
0.030
 Why?
Hemodynamics
1
2018
264
0.030
 Why?
Internationality
1
2016
46
0.030
 Why?
Patient Readmission
1
2018
246
0.030
 Why?
Blood Transfusion
1
2016
129
0.030
 Why?
Intraoperative Complications
1
1996
113
0.030
 Why?
International Normalized Ratio
1
2014
28
0.030
 Why?
Ankle Brachial Index
1
2014
15
0.030
 Why?
Mobility Limitation
1
2014
27
0.030
 Why?
Drug Resistance
1
2014
68
0.030
 Why?
Animals
4
2002
13507
0.030
 Why?
Aryldialkylphosphatase
1
2013
5
0.030
 Why?
Blood Pressure
2
2007
537
0.030
 Why?
Sex Factors
2
2009
729
0.030
 Why?
Biotransformation
1
2013
86
0.030
 Why?
Exercise Test
1
2014
144
0.030
 Why?
Oxygen Consumption
1
2014
200
0.030
 Why?
Polymorphism, Genetic
1
2013
184
0.020
 Why?
Adrenergic beta-1 Receptor Antagonists
1
2012
7
0.020
 Why?
Alleles
1
2013
278
0.020
 Why?
Drug Antagonism
1
2012
8
0.020
 Why?
Child
1
2005
7229
0.020
 Why?
Embolic Protection Devices
1
2012
7
0.020
 Why?
Critical Pathways
1
2012
36
0.020
 Why?
Injections, Intravenous
1
2012
135
0.020
 Why?
Secondary Prevention
1
2012
85
0.020
 Why?
Natriuretic Peptide, Brain
1
2011
32
0.020
 Why?
Models, Statistical
1
2012
231
0.020
 Why?
Kaplan-Meier Estimate
1
2011
485
0.020
 Why?
Cross-Over Studies
1
2011
239
0.020
 Why?
Cells, Cultured
1
2013
1588
0.020
 Why?
Femur Head
1
2009
26
0.020
 Why?
Confidence Intervals
1
2009
159
0.020
 Why?
Probability
2
2001
173
0.020
 Why?
Area Under Curve
1
2009
183
0.020
 Why?
Hemorheology
1
2009
6
0.020
 Why?
Multiple Myeloma
1
2004
3050
0.020
 Why?
Receptors, Thrombin
1
2009
14
0.020
 Why?
Adenosine Diphosphate
1
2009
20
0.020
 Why?
Polysaccharides
1
2009
55
0.020
 Why?
Linear Models
1
2009
292
0.020
 Why?
Cross-Sectional Studies
1
2014
1686
0.020
 Why?
Patient Education as Topic
1
2011
322
0.020
 Why?
Collagen
1
2009
213
0.020
 Why?
Ankle
1
2007
15
0.020
 Why?
Brachial Artery
1
2007
17
0.020
 Why?
Injections, Intramuscular
1
2007
57
0.020
 Why?
Calcium-Binding Proteins
1
2007
58
0.020
 Why?
Disease Progression
1
2010
873
0.020
 Why?
Heart Conduction System
1
2006
25
0.020
 Why?
Combined Modality Therapy
2
1999
639
0.020
 Why?
Sex Distribution
1
2006
138
0.020
 Why?
Age Distribution
1
2006
175
0.020
 Why?
Body Mass Index
1
2009
692
0.020
 Why?
Genetic Therapy
1
2007
122
0.020
 Why?
Insurance, Health
1
2006
133
0.010
 Why?
Ultrasonography, Interventional
1
2006
139
0.010
 Why?
Societies, Medical
1
2005
202
0.010
 Why?
Platelet Adhesiveness
1
2004
14
0.010
 Why?
Abnormalities, Multiple
1
2005
168
0.010
 Why?
Platelet Count
1
2004
76
0.010
 Why?
Vascular Endothelial Growth Factors
1
2003
15
0.010
 Why?
Adenoviridae
1
2003
47
0.010
 Why?
Injections, Subcutaneous
1
2003
51
0.010
 Why?
Smoking
1
2006
518
0.010
 Why?
Endpoint Determination
1
2002
26
0.010
 Why?
Vascular Endothelial Growth Factor A
1
2003
187
0.010
 Why?
Instillation, Drug
1
2002
2
0.010
 Why?
Echocardiography
1
2005
416
0.010
 Why?
Catheters, Indwelling
1
2001
59
0.010
 Why?
Angina Pectoris
1
2001
20
0.010
 Why?
Survival Analysis
1
2002
673
0.010
 Why?
Hypoglycemic Agents
1
2002
217
0.010
 Why?
District of Columbia
1
2000
23
0.010
 Why?
Insulin
1
2002
484
0.010
 Why?
Tunica Intima
1
2000
56
0.010
 Why?
Partial Thromboplastin Time
1
1999
14
0.010
 Why?
Cineangiography
1
1999
10
0.010
 Why?
Prothrombin Time
1
1999
18
0.010
 Why?
United States Food and Drug Administration
1
1999
96
0.010
 Why?
Radiographic Image Enhancement
1
1999
30
0.010
 Why?
Coronary Thrombosis
1
1999
23
0.010
 Why?
Coronary Circulation
1
1999
58
0.010
 Why?
Regional Blood Flow
1
1999
107
0.010
 Why?
Dogs
1
1999
183
0.010
 Why?
Radiotherapy, Adjuvant
1
1999
64
0.010
 Why?
Safety
1
1999
80
0.010
 Why?
Swine
1
2000
427
0.010
 Why?
Sensitivity and Specificity
1
2000
883
0.010
 Why?
Postoperative Care
1
1998
105
0.010
 Why?
Lipids
1
1998
160
0.010
 Why?
Disease Models, Animal
1
1999
1486
0.010
 Why?
Mice
1
1999
5958
0.000
 Why?
Saucedo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (377) concept(s)
_
Co-Authors Expand Description
See all (4) people
_
Similar People Expand Description
See all (27) people
_
Same Department Expand Description
Search Department